Current research and clinical trials for a vaccine against Chikungunya virus

Author(s): Singh P | Chhabra M | Mittal V | Sharma P | Rizvi MA | Chauhan LS | Rai A
Volume: 2013
Issue: default
Year: 2013

Melanoma vaccines: trials and tribulations

Author(s): Dillman RO
Volume: 2013
Issue: default
Year: 2013

Forced degradation studies: an essential tool for the formulation development of vaccines

Author(s): Hasija M | Li L | Rahman N | Ausar SF
Volume: 2013
Issue: default
Year: 2013

Review of recent literature on microneedle vaccine delivery technologies

Author(s): Vrdoljak A
Volume: 2013
Issue: default
Year: 2013

Key feasibility considerations when conducting vaccine clinical trials in Asia–Pacific countries

Author(s): Lansang EZ | Tan K | Nayak S | Lee KJ | Wai K
Volume: 2013
Issue: default
Year: 2013

New recombinant vaccines for the prevention of meningococcal B disease

Author(s): Taha MK | Deghmane AE
Volume: 2012
Issue: default
Year: 2012

Advances in the development of vaccines for dengue fever

Author(s): Simmons M | Teneza-Mora N | Putnak R
Volume: 2012
Issue: default
Year: 2012

Cytolethal distending toxin as virulence factor, protective antigen, and target for vaccine development

Author(s): Lagergård T | Keith J
Volume: 2012
Issue: default
Year: 2012

Assessment of chicken protection against Campylobacter jejuni infection by immunization with avirulent Salmonella enterica sv. Typhimurium strain producing Campylobacter CjaD/Pal protein

Author(s): Łaniewski P | Lis M | Wyszyńska A | Majewski P | Godlewska R | Jagusztyn-Krynicka EK
Volume: 2012
Issue: default
Year: 2012

Reasons for not having received influenza vaccination and its predictors in Canadians

Author(s): Chen Y | Wu J | Yi QL | Laroche J | Wong T
Volume: 2012
Issue: default
Year: 2012

Realizing the promise of breast cancer vaccines

Author(s): Jackson E | Soliman H
Volume: 2012
Issue: default
Year: 2012

A new forum to spread the word on vaccine research

Author(s): Pasetti MF
Volume: 2011
Issue: default
Year: 2011

The utility of human challenge studies in vaccine development: lessons learned from cholera

Author(s): Shirley DT | McArthur MA
Volume: 2011
Issue: default
Year: 2011

Recombinant Rhipicephalus appendiculatus gut (Ra86) and salivary gland cement (Trp64) proteins as candidate antigens for inclusion in tick vaccines: protective effects of Ra86 on infestation with adult R. appendiculatus

Author(s): Saimo M | Odongo DO | Mwaura S | Vlak JM | Musoke AJ | Lubega GW | Bishop RP | van Oers MM
Volume: 2011
Issue: default
Year: 2011